kardashian glp-1 Lemme Inc., co-founded by Kourtney Kardashian, was accused in a new proposed class action for advertising its GLP1 supplement as working like FDA approved medications like semaglutide and tirzepatide. #ozempic # kardashians #wegovy # Kourtney Kardashian Barker's supplement brand,

When used responsibly under medical supervision, it may be a powerful component of a wellness strategy focused on recovery, performance, body composition, sleep, and healthy aging

Researchers should carefully evaluate the remaining evidence base in light of these developments

It means the regulatory pathway is narrower than it was in prior years, and consumers should be aware of that shift when making informed decisions about their treatment options

Dont run this protocol if youre subject to drug testing

Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)

Understand GLP-1 positioning